A role for perlecan in the suppression of growth and invasion in fibrosarcoma cells

Cancer Research

Volumn 57, Issue 11, 1997, Pages 2130-2136

  Mathiak, Micaela ^a   Yenisey, Cigdem ^b   Grant, Derrick S ^a,b   Sharma, Bela ^a   Iozzo, Renato V ^a,c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERLECAN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BASEMENT MEMBRANE; CANCER GROWTH; CANCER INVASION; CELL MIGRATION; CELL SURFACE; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; FIBROSARCOMA; GROWTH INHIBITION; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

ANIMALS; CELL ADHESION; CELL DIVISION; CELL MOVEMENT; COLLAGEN; DNA, ANTISENSE; FIBROBLAST GROWTH FACTOR 2; FIBROSARCOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPARAN SULFATE PROTEOGLYCANS; HEPARITIN SULFATE; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; PROTEOGLYCANS; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0030958891     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Noonan, D. M., Fulle, A., Valente, P., Cai, S., Horigan, E., Sasaki, M., Yamada, Y., and Hassell, J. R. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J. Biol. Chem., 266: 22939-22947, 1991.
2. Murdoch, A. D., Dodge, G. R., Cohen, I., Tuan, R. S., and Iozzo, R. V. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J. Biol. Chem., 267: 8544-8557, 1992.
3. Iozzo, R. V. Biosynthesis of heparan sulfate proteoglycan by human colon carcinoma cells and its localization at the cell surface. J. Cell Biol., 99: 403-417, 1984.
4. Battaglia, C., Aumailley, M., Mann, K., Mayer, U., and Timpl, R. Structural basis of β1 integrin-mediated cell adhesion to a large heparan sulfate proteoglycan from basement membranes. Eur. J. Cell Biol., 61: 92-99, 1993.
5. Hayashi, K., Madri, J. A., and Yurchenco, P. D. Endothelial cells interact with the core protein of basement membrane perlecan through β1 and β3 integrins: an adhesion modulated by glycosaminoglycans. J. Cell Biol., 119: 945-959, 1992.
6. Iozzo, R. V. Perlecan: a gem of a proteoglycan. Matrix Biol., 14: 203-208, 1994.
7. Iozzo, R. V., and Murdoch, A. D. Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J., 10: 598-614, 1996.
8. Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P., and Ornitz, D. M. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell, 64: 841-848, 1991.
9. Rapraeger, A. C., Krufka, A., and Olwin, B. B. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science (Washington DC), 22: 1705-1708, 1991.
10. Roberts, R., Gallagher, J., Spooncer, E., Allen, T. D., Bloomfield, F., and Dexter, T. M. Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature (Lond.), 332: 376-378, 1988.
11. Turnbull, J. E., Fernig, D. G., Ke, Y., Wilkinson, M. C., and Gallagher, J. T. Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. J. Biol. Chem., 267: 10337-10341, 1992.
12. Ornitz, D. M., Herr, A. B., Nilsson, M., Westman, J., Svahn, C., and Waksman, G. FGF binding and FGF receptor activation by synthetic heparan-derived di-and trisaccharides. Science (Washington DC), 268: 432-436, 1995.
13. Aviezer, D., Levy, E., Safran, M., Svahn, C., Buddecke, E., Schmidt, A., David, G., Vlodavsky, I., and Yayon, A. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J. Biol. Chem., 269: 114-121, 1994.
14. Aviezer, D., Hecht, D., Safran, M., Eisinger, M., David, G., and Yayon, A. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell, 79: 1005-1013, 1994.
15. Folkman, J., Klagsbrun, M., Sasse, J., Wadzinski, M., Ingber, D., and Vlodavsky, I. A heparin-binding angiogenic protein, basic fibroblast growth factor, is stored within basement membrane. Am. J. Pathol., 130: 393-400, 1988.
16. Vigny, M., Ollier-Hartmann, M. P., Lavigne, M., Fayein, N., Jeanny, J. C., Laurent, M., and Courtois, Y. Specific binding of basic fibroblast growth factor to basement membrane-like structures and to purified heparan sulfate proteoglycan of the EHS tumor. J. Cell. Physiol., 137: 321-328, 1988.
17. Ohtani, H., Nakamura, S., Watanabe, Y., Mizoi, T., Saku, T., and Nagura, H. Immunocytochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract. Lab. Invest., 68: 520-527, 1993.
18. Timar, J., Ladanyi, A., Lapis, K., and Moczar, M. Differential expression of proteoglycans on the surface of human melanoma cells characterized by altered experimental metastatic potential. Am. J. Pathol., 141: 467-474, 1992.
19. Cohen, I. R., Murdoch, A. D., Naso, M. F., Marchetti, D., Berd, D., and Iozzo, R. V. Abnormal expression of perlecan proteoglycan in metastatic melanomas. Cancer Res., 54: 5771-5774, 1994.
20. Marchetti, D., Menter, D., Jin, L., Nakajima, M., and Nicolson, G. L. Nerve growth factor effects on human and mouse melanoma cell invasion and heparanase production. Int. J. Cancer, 55: 692-699, 1993.
21. Imamura, T., Tokita, Y., and Mitsui, Y. Contact with basement membrane heparan sulfate enhances the growth of transformed vascular eudothelial cells, but suppresses normal cells. Cell Struct. Funct., 16: 225-230, 1991.
22. Aviezer, D., Iozzo, R. V., Noonan, D. M., and Yayon, A. Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA. Mol. Cell. Biol., 17: 1938-1946, 1977.
23. Iozzo, R. V., Cohen, I. R., Grässel, S., and Murdoch, A. D. The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem. J., 302: 625-639, 1994.
24. Saksela, O., Moscatelli, D., Sommer, A., and Rifkin, D. B. Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J. Cell Biol., 107: 743-751, 1988.
25. Saksela, O., and Rifkin, D. B. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J. Cell Biol., 110: 767-775, 1990.
26. Whitelock, J. M., Murdoch, A. D., Iozzo, R. V., and Underwood, P. A. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin collagenase, plasmin and heparanases. J. Biol. Chem., 271: 10079-10086, 1996.
27. Kleinman, H. K., McGarvey, M. L., Hassell, J. R., Star, V. L., Cannon, F. B., Laurie, G. W., and Martin, G. R. Basement membrane complexes with biological activity. Biochemistry, 25: 312-318, 1986.
28. Murdoch, A. D., Liu, B., Schwarting, R., Tuan, R. S., and Iozzo, R. V. Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J. Histochem. Cytochem., 42: 239-249, 1994.
29. Grässel, S., Cohen, I. R., Murdoch, A. D., Eichstetter, I., and Iozzo, R. V. The proteoglycan perlecan is expressed in the erythroleukemia cell line K562 and is upregulated by sodium butyrate and phorbol ester. Mol. Cell. Biochem., 145: 61-68, 1995.
30. Buttke, T. M., McCubrey, J. A., and Owen, T. C. Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines. J. Immunol. Methods, 157: 233-240, 1993.
31. Santra, M., Skorski, T., Calabretta, B., Lattime, E. C., and Iozzo, R. V. De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. Proc. Natl. Acad. Sci. USA, 92: 7016-7020, 1995.
32. Kibbey, M. C., Grant, D. S., and Kleinman, H. K. Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo matrigel model. J. Natl. Cancer Inst. (Bethesda), 84: 1633-1638, 1997.
33. Albini, A., Iwamoto, Y., Kleinman, H. K., Martin, G. R., Aaronson, S. A., Kozlowski, J. M., and McEwan, R. N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res., 47: 3239-3245, 1987.
34. Ornitz, D. M., Yayon, A., Flanagan, J. G., Svahn, C. M., Levi, E., and Leder, P. Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol., 12: 240-247, 1992.
35. Fannon, M., and Nugent, M. A. Basic fibroblast growth factor binds its receptors, is internalized, and stimulates DNA synthesis in Balb/c3T3 cells in the absence of heparan sulfate. J. Biol. Chem., 271: 17949-17956, 1996.
36. Klein, G., Conzelmann, S., Beck, S., Timpl, R., and Müller, C. A. Perlecan in human bone marrow: a growth-factor presenting, but anti-adhesive, extracellular matrix component for hematopoietic cells. Matrix Biol., 14: 457-465, 1995.
37. Gauer, S., Schulzelohoff, E., Schleieher, E., and Sterzel, R. B. Glomerular basement membrane-derived perlecan inhibits mesangial cell adhesion to fibronectin. Eur. J. Cell Biol., 70: 233-242, 1996.
38. Frieser, M., Hallmann, R., Johansson, S., Vestweber, D., Goodman, S. L., and Sorokin, L. Mouse polymorphonuclear granulocyte binding to extracellular matrix molecules involves β-integrins. Eur. J. Immunol., 26: 3127-2136, 1996.